← Back to Search

Behavioural Intervention

Experimental and Reference Devices for Communication for Speech Disorder

N/A

Waitlist Available

Led By Gianluca DeLuca

Research Sponsored by Altec Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 30 mins to 2 hours

Awards & highlights

No Placebo-Only Group

Summary

This trial will test MyoVoice, a device that helps people who can't speak naturally by using muscle signals to create speech. It targets patients who lost their voice due to cancer surgery. MyoVoice works by reading muscle signals when someone mouths words and turning those signals into speech. The trial will compare MyoVoice to other speech aids to see how well it works and how easy it is to use.

Eligible Conditions

Speech Disorder
Speech Disorders in Children
Speech and Language Therapy
Alaryngeal Speech
Assistive Communication Devices
Speech Perception
Speech Clarity

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 30 mins to 2 hours

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~30 mins to 2 hours

This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 mins to 2 hours for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Loudness Recognition Accuracy

Pitch Recognition Accuracy

Speech Naturalness

Secondary study objectives

Acceptability

Acoustic Identity

Emotional Content

+2 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Experimental and Reference Devices for CommunicationExperimental Treatment2 Interventions

Each participant listens to speech produced by an experimental ("MyoVoice") and reference (electrolarynx) systems that are used to communicate. Participants rate the naturalness of the speech produced from each device (audio files presented in a randomized order). Duration: 30 mins to 1 hour.

Group II: Development of Speech CorporaActive Control1 Intervention

Each participant produces a list of speech tasks that include syllables, phrases, reading passages, and open-ended questions using the MyoVoice system. Myovoice pitch and loudness recognition accuracy of speech is evaluated. Duration: 30 mins to 2 hours.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Experimental System: MyoVoice

2021

N/A

~30

Reference System: Electrolarynx

2021

N/A

~30